Showing results (1191-1200 of 5,269) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|July 5, 2024
Aberrant early hematopoietic progenitor formation marks the onset of hematopoietic defects in Shwachman-Diamond syndromeAlejandra Lagos-Monzon, Stephanie Ng, Alice M Luca, et al.
European Journal of Haematology|July 11, 2024
Use of allopurinol to manage skewed 6-mercaptopurine metabolism in pediatric maintenance acute lymphoblastic leukemia treatmentMandee Lines, Ryan M Kemper, Jordan Wallace, et al.
European Journal of Haematology|July 11, 2024
Characteristics of large granular lymphocyte leukemia associated with variable common immunodeficiency disorders: A study of 12 casesC Gueuning, E Lazaro, H Dupuy, et al.
European Journal of Haematology|August 27, 2024
MYC translocation is a valuable marker for the development and relapse of extramedullary disease in multiple myelomaYuhang Song, Jianhua Du, Xianghong Jin, et al.
European Journal of Haematology|June 19, 2024
Childhood autoimmune hemolytic anemia: A scoping reviewCaseng Zhang, Danielle Charland, Katie O'Hearn, et al.
European Journal of Haematology|June 10, 2024
The expression of Galectin-9 correlates with mTOR and AMPK in murine colony-forming erythroid progenitorsTetsuo Tsukamoto
European Journal of Haematology|May 9, 2024
Effectiveness and safety of belantamab mafodotin in patients with relapsed or refractory multiple myeloma in real-world setting: The ALFA studyMurielle Roussel, Nathalie Texier, Virginie Nael, et al.
European Journal of Haematology|May 23, 2024
Rapid response system for critically ill patients with haematological malignancies: A pre- and post-intervention studyN Mauz, M Bouisse, J Y Cahn, et al.
European Journal of Haematology|April 15, 2024
Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trialTim Richardson, Christof Scheid, Marco Herling, et al.
European Journal of Haematology|April 24, 2024
Evaluation of soluble P-selectin as a predictive biomarker in acute symptomatic pulmonary embolism: Insights from a prospective observational studyCrhistian-Mario Oblitas, Pablo Demelo-Rodríguez, Marina López-Rubio, et al.
Pageof 527